Corroborating publications towards a robust CD4 T‐cell response at around 6‐month recovery from COVID‐19 also indicate the involvement of polyfunctional T cells involving IL‐2, IFNγ and TNFα [29, 30]. The gene discussed is IL2; the disease is COVID-19.